PEAK6 Investments’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

PEAK6 Investments’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,666	Closed	-$1.27K	–	4939
2023 Q1	$1.27K	Hold	66,666	–	–	﹤0.01%	4086
2022 Q4	$9.93K	Hold	66,666	–	–	﹤0.01%	4086
2022 Q3	$11K	Hold	66,666	–	–	﹤0.01%	4592
2022 Q2	$8K	Hold	66,666	–	–	﹤0.01%	5850
2022 Q1	$53K	Hold	66,666	–	–	﹤0.01%	4531
2021 Q4	$40K	Hold	66,666	–	–	﹤0.01%	4679
2021 Q3	$63K	Hold	66,666	–	–	﹤0.01%	4534
2021 Q2	$99K	Buy	+66,666	New	+$58.2K	﹤0.01%	4404

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

PEAK6 Investments's PEARW Position: Q2 2023 in Review

PEAK6 Investments sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 66,666 shares — an estimated $1.27K sold.

PEAK6 Investments first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $99K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

PEAK6 Investments reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
PEAK6 Investments sold 66,666 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $1.27K.
PEAK6 Investments first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
PEAK6 Investments's Pear Therapeutics, Inc. Warrant position peaked at $99K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.